Endocannabinoids in neuroendopsychology: Multiphasic control of mitochondrial function

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 367, Issue 1607, 2012, Pages 3342-3352

  Nunn, Alistair ^a   Guy, Geoffrey ^b   Bell, Jimmy D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b Porton Down Science Park   (United Kingdom)

Author keywords

Endocannabinoid; Hormesis; Mitochondria; Redox

Indexed keywords

EID: 84868120950     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2011.0393     Document Type: Review

References (106)

1. Howlett, A. C., Blume, L. C. & Dalton, G. D. 2010 CB(1) cannabinoid receptors and their associated proteins. Curr. Med. Chem. 17, 1382-1393.(doi:10.2174/092986710790980023)
2. Velasco, G., Galve-Roperh, I., Sanchez, C., Blazquez, C., Haro, A. & Guzman, M. 2005 Cannabinoids and ceramide: two lipids acting hand-by-hand. Life Sci. 77, 1723-1731.(doi:10.1016/j.lfs.2005.05.015)
3. Vara, D., Salazar, M., Olea-Herrero, N., Guzman, M., Velasco, G. & az-Laviada, I. 2011 Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ. 18, 1099-1111.(doi:10.1038/cdd.2011.32)
4. Puighermanal, E., Marsicano, G., Busquets-Garcia, A., Lutz, B., Maldonado, R. & Ozaita, A. 2009 Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat. Neurosci. 12, 1152-1158.(doi:10.1038/nn.2369)
5. Gomez, O., Sanchez-Rodriguez, A., Le, M., Sanchez-Caro, C., Molina-Holgado, F. & Molina-Holgado, E. 2011 Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways. Br. J. Pharmacol. 163, 1520-1532.(doi:10.1111/j.1476-5381.2011.01414.x)
6. Palazuelos, J., Ortega, Z., az-Alonso, J., Guzman, M. & Galve-Roperh, I. 2012 CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling. J. Biol. Chem. 287, 1198-1209.(doi:10.1074/jbc.M111.291294)
7. Salazar, M. et al. 2009 Cannabinoid action induces autophagymediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Invest. 119, 1359-1372.(doi:10.1172/JCI37948)
8. Phillis, J. W., Horrocks, L. A. & Farooqui, A. A. 2006 Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res. Rev. 52, 201-243.(doi:10.1016/j.brainresrev.2006.02.002)
9. Serhan, C. N., Chiang, N. & van Dyke, T. E. 2008 Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349-361.(doi:10.1038/nri2294)
10. Dietrich, A. & McDaniel, W. F. 2004 Endocannabinoids and exercise. Br. J. Sports Med. 38, 536-541.(doi:10.1136/bjsm.2004.011718)
11. Kirkham, T. C. & Williams, C. M. 2001 Synergistic efects of opioid and cannabinoid antagonists on food intake. Psychopharmacology (Berl.) 153, 267-270.(doi:10.1007/s002130000596)
12. Matias, I., Cristino, L. & Di Marzo, V. 2008 Endocannabinoids: some like it fat (and sweet too). J. Neuroendocrinol. 20(Suppl. 1), 100-109.(doi:10.1111/j.1365-2826.2008.01678.x)
13. Mechoulam, R., Spatz, M. & Shohami, E. 2002 Endocannabinoids and neuroprotection. Sci. STKE. 2002, RE5.(doi:10.1126/stke.2002.129.re5)
14. Pacher, P. & Hasko, G. 2008 Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 153, 252-262.(doi:10.1038/sj.bjp.0707582)
15. Gammon, C.M., Freeman Jr, G. M., Xie, W., Petersen, S. L. & Wetsel, W. C. 2005 Regulation of gonadotropinreleasing hormone secretion by cannabinoids. Endocrinology 146, 4491-4499.(doi:10.1210/en.2004-1672)
16. Fride, E. & Mechoulam, R. 1993 Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231, 313-314.(doi:10.1016/0014-2999(93)90468-W)
17. Nunn, A. V., Guy, G. W. & Bell, J. D. 2010 Endocannabinoids, FOXO and the metabolic syndrome: redox, function and tipping point: the view from two systems. Immunobiology 215, 617-628.(doi:10.1016/j.imbio.2009.03.005)
18. Pertwee, R. G. 2005 The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J. 7, E625-E654.(doi:10.1208/aapsj070364)
19. Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M.W. & Sheu, S. S. 2004 Calcium, ATP, andROS: amitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 287, C817-C833.(doi:10.1152/ajpcell.00139.2004)
20. Howlett, A. C. & Mukhopadhyay, S. 2000 Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem. Phys. Lipids 108, 53-70.(doi:10.1016/S0009-3084(00)00187-0)
21. 2+ signalling. Cell Calcium 45, 611-624.(doi:10.1016/j.ceca.2009.03.003)
22. Pisanti, S. & Bifulco, M. 2009 Endocannabinoid system modulation in cancer biology and therapy. Pharmacol. Res. 60, 107-116.(doi:10.1016/j.phrs.2009.03.011)
23. Fischbach, T., Greffrath, W., Nawrath, H. & Treede, R. D. 2007 Effects of anandamide and noxious heat on intracellular calcium concentration in nociceptive DRG neurons of rats. J. Neurophysiol. 98, 929-938.(doi:10.1152/jn.01096.2006)
24. Toth, B. I. et al. 2011 Endocannabinoidsmodulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. J. Invest. Dermatol. 131, 1095-1104.(doi:10.1038/jid.2010.421)
25. Moreira, F. A., Aguiar, D. C., Terzian, A. L., Guimaraes, F. S. & Wotjak, C. T. 2012 Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides ofone coin? Neuroscience 204, 186-192.(doi:10.1016/j.neuroscience.2011.08.046)
26. Brailoiu, G. C., Oprea, T. I., Zhao, P., Abood, M. E. & Brailoiu, E. 2011 Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide. J. Biol. Chem. 286, 29166-29174.(doi:10.1074/jbc.M110.217463)
27. Erusalimsky, J. D. & Moncada, S. 2007 Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. Arterioscler. Thromb. Vasc. Biol. 27, 2524-2531.(doi:10.1161/ATVBAHA.107.151167)
28. Martinez-Ruiz, A., Cadenas, S. & Lamas, S. 2011 Nitric oxide signaling: classical, less classical, and nonclassical mechanisms. Free Radic. Biol. Med. 51, 17-29.(doi:10.1016/j.freeradbiomed.2011.04.010)
29. Howlett, A. C., Mukhopadhyay, S. & Norford, D. C. 2006 Endocannabinoids and reactive nitrogen and oxygen species in neuropathologies. J. Neuroimmune Pharmacol. 1, 305-316.(doi:10.1007/s11481-006-9022-6)
30. Oddi, S., Latini, L., Viscomi, M. T., Bisicchia, E., Molinari, M. & Maccarrone, M. 2012 Distinct regulation of nNOS and iNOS by CB(2) receptor in remote delayed neurodegeneration. J. Mol. Med. (Berl.) 90, 371-387.(doi:10.1007/s00109-011-0846-z)
31. Carney, S. T., Lloyd, M. L., MacKinnon, S. E., Newton, D. C., Jones, J.D., Howlett, A. C. & Norford, D. C. 2009 Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells. J. Neuroimmune Pharmacol. 4, 338-349.(doi:10.1007/s11481-009-9153-7)
32. Signorello, M. G., Giacobbe, E., Passalacqua, M. & Leoncini, G. 2011 The anandamide effect on NO/ cGMP pathway in human platelets. J. Cell Biochem. 112, 924-932.(doi:10.1002/jcb.23008)
33. Poblete, I. M., Orliac, M. L., Briones, R., Dler-Graschinsky, E. & Huidobro-Toro, J. P. 2005 Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed. J. Physiol. 568, 539-551.(doi:10.1113/jphysiol.2005.094292)
34. Pacher, P. & Mackie, K. 2012 Interplay of cannabinoid 2 CB2 receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration. J. Mol. Med. (Berl.) 90, 347-351.(doi:10.1007/s00109-012-0884-1)
35. Colombini, M. 2010 Ceramide channels and their role in mitochondria-mediated apoptosis. Biochim. Biophys. Acta 1797, 1239-1244.(doi:10.1016/j.bbabio.2010.01.021)
36. Novgorodov, S. A. & Gudz, T. I. 2009 Ceramide and mitochondria in ischemia/reperfusion. J. Cardiovasc.Pharmacol. 53, 198-208.(doi:10.1097/FJC.0b013e31819b52d5)
37. Mullen, T. D., Hannun, Y. A. & Obeid, L. M. 2012 Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem. J. 441, 789-802.(doi:10.1042/BJ20111626)
38. Ponnusamy, S., Meyers-Needham, M., Senkal, C. E., Saddoughi, S. A., Sentelle, D., Selvam, S. P., Salas, A. & Ogretmen, B. 2010 Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncol. 6, 1603-1624.(doi:10.2217/fon.10.116)
39. Gustafsson, K., Sander, B., Bielawski, J., Hannun, Y. A. & Flygare, J. 2009 Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism. Mol. Cancer Res. 7, 1086-1098.(doi:10.1158/1541-7786.MCR-08-0361)
40. Blackstone, N. W. 2000 Redox control and the evolution of multicellularity. Bioessays 22, 947-953.(doi:10.1002/1521-1878(200010)22:10947::AID-BIES103.0.CO;2-W)
41. Brigelius-Flohe, R. & Flohe, L. 2011 Basic principles and emerging concepts in the redox control of transcription factors. Antioxid. Redox Signal. 15, 2335-2381.(doi:10.1089/ars.2010.3534)
42. Hurd, T. R., DeGennaro, M. & Lehmann, R. 2012 Redox regulation of cell migration and adhesion. Trends Cell Biol. 22, 107-115.(doi:10.1016/j.tcb.2011.11.002)
43. Janssen-Heininger, Y. M., Mossman, B. T., Heintz, N. H., Forman, H. J., Kalyanaraman, B., Finkel, T., Stamler, J. S., Rhee, S. G. & van der Vliet, A. 2008 Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic. Biol. Med. 45, 1-17.(doi:10.1016/j.freeradbiomed.2008.03.011)
44. Ottaviano, F. G., Handy, D. E. & Loscalzo, J. 2008 Redox regulation in the extracellular environment. Circ. J. 72, 1-16.(doi:10.1253/circj.72.1)
45. Sarsour, E. H., Kumar, M. G., Chaudhuri, L., Kalen, A. L. & Goswami, P. C. 2009 Redox control of the cell cycle in health and disease. Antioxid. Redox Signal. 11, 2985-3011.(doi:10.1089/ars.2009.2513)
46. Yan, Z. & Banerjee, R. 2010 Redox remodeling as an immunoregulatory strategy. Biochemistry 49, 1059-1066.(doi:10.1021/bi902022n)
47. Antico Arciuch, V. G., Elguero, M. E., Poderoso, J. J. & Carreras, M. C. 2012 Mitochondrial regulation of cell cycle and proliferation. Antioxid. Redox Signal. 16, 1150-1180.(doi:10.1089/ars.2011.4085)
48. Jones, D. P. 2010 Redox sensing: orthogonal control in cell cycle and apoptosis signalling. J. Intern. Med. 268, 432-448.(doi:10.1111/j.1365-2796.2010.02268.x)
49. Jones, D. P. & Go, Y. M. 2010 Redox compartmentalization and cellular stress. Diab. Obes. Metab. 12(Suppl. 2), 116-125.(doi:10.1111/j.1463-1326.2010.01266.x)
50. Han, K.H. et al. 2009 CB1 andCB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages. Cardiovasc. Res. 84, 378-386.(doi:10.1093/cvr/cvp240)
51. Mukhopadhyay, P. et al. 2010 CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. Br. J. Pharmacol. 160, 657-668.(doi:10.1111/j.1476-5381.2010.00769.x)
52. Alexander, A. & Walker, C. L. 2011 The role of LKB1 and AMPK in cellular responses to stress and damage. FEBS Lett. 585, 952-957.(doi:10.1016/j.febslet.2011.03.010)
53. Horvath, B., Mukhopadhyay, P., Hasko, G. & Pacher, P. 2012 The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications. Am. J. Pathol. 180, 432-442.(doi:10.1016/j.ajpath.2011.11.003)
54. Rajesh, M., Mukhopadhyay, P., Hasko, G., Liaudet, L., Mackie, K. & Pacher, P. 2010 Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. Br. J. Pharmacol. 160, 688-700.(doi:10.1111/j.1476-5381.2010.00712.x)
55. Ito, T., Mishima, Y., Ito, A., Kameyama, N., Harada, H., Iwata, O., Watanabe, S. & Ushijima, K. 2011 Propofol protects against anandamide-induced injury in human umbilical vein endothelial cells. Kurume Med.J. 58, 15-20.(doi:10.2739/kurumemedj.58.15)
56. Bains, R., Moe, M. C., Vinje, M. L. & Berg-Johnsen, J. 2009 Sevoflurane and propofol depolarize mitochondria in rat and human cerebrocortical synaptosomes by different mechanisms. Acta Anaesthesiol. Scand. 53, 1354-1360.(doi:10.1111/j.1399-6576.2009.02047.x)
57. Siegmund, S. V., Qian, T., de Minicis, S., Harvey-White, J., Kunos, G., Vinod, K. Y., Hungund, B. & Schwabe, R. F. 2007 The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J. 21, 2798-2806.(doi:10.1096/fj.06-7717com)
58. Schieke, S. M. & Finkel, T. 2006 Mitochondrial signaling, TOR, and life span. Biol. Chem. 387, 1357-1361.(doi:10.1515/BC.2006.170)
59. Schieke, S. M., Phillips, D., McCoy Jr, J. P., Aponte, A. M., Shen, R. F., Balaban, R. S. & Finkel, T. 2006 The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidativecapacity. J. Biol. Chem. 281, 27643-27652.(doi:10.1074/jbc.M603536200)
60. Blagosklonny, M. V. 2010 Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans). Cell Cycle 9, 683-688.(doi:10.4161/cc.9.4.10766)
61. Rehman, J. 2010 Empowering self-renewal and differentiation: the role of mitochondria in stem cells. J. Mol. Med. (Berl.) 88, 981-986.(doi:10.1007/s00109-010-0678-2)
62. Oudin, M. J., Hobbs, C. & Doherty, P. 2011 DAGLdependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis. Eur. J. Neurosci. 34, 1634-1646.(doi:10.1111/j.1460-9568.2011.07831.x)
63. Giorgi, C., De Stefani, D., Bononi, A., Rizzuto, R. & Pinton, P. 2009 Structural and functional link between the mitochondrial network and the endoplasmic reticulum. Int. J. Biochem. Cell Biol. 41, 1817-1827.(doi:10.1016/j.biocel.2009.04.010)
64. Park, J., Lee, J. & Choi, C. 2011 Mitochondrial network determines intracellular ROS dynamics and sensitivity to oxidative stress through switching inter-mitochondrial messengers. PLoS ONE 6, e23211.(doi:10.1371/journal.pone.0023211)
65. Carlucci, A., Lignitto, L. & Feliciello, A. 2008 Control of mitochondria dynamics and oxidative metabolism by cAMP, AKAPs and the proteasome. Trends Cell Biol. 18, 604-613.(doi:10.1016/j.tcb.2008.09.006)
66. Fujimoto, M. & Hayashi, T. 2011 New insights into the role of mitochondria-associated endoplasmic reticulum membrane. Int. Rev. Cell Mol. Biol. 292, 73-117.(doi:10.1016/B978-0-12-386033-0.00002-5)
67. Ziolkowski, W. et al. 2010 Methyl-beta-cyclodextrin induces mitochondrial cholesterol depletion and alters the mitochondrial structure and bioenergetics. FEBS Lett. 584, 4606-4610.(doi:10.1016/j.febslet.2010.10.023)
68. Poston, C. N., Duong, E., Cao, Y. & Bazemore-Walker, C. R. 2011 Proteomic analysis of lipid raft-enriched membranes isolated from internal organelles. Biochem. Biophys. Res. Commun. 415, 355-360.(doi:10.1016/j.bbrc.2011.10.072)
69. Ciarlo, L., Manganelli, V., Garofalo, T., Matarrese, P., Tinari, A., Misasi, R., Malorni, W. & Sorice, M. 2010 Association of fission proteins with mitochondrial raftlike domains. Cell Death Differ. 17, 1047-1058.(doi:10.1038/cdd.2009.208)
70. Mollinedo, F. et al. 2011 Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria. Cell Death Dis. 2, e158.(doi:10.1038/cddis.2011.41)
71. Moon, S. H., Jenkins, C. M., Liu, X., Guan, S., Mancuso, D. J. & Gross, R. W. 2012 Activation of mitochondrial calcium-independent phospholipase a2gamma (ipla2gamma) by divalent cations mediating arachidonate release and the production of downstream eicosanoids. J. Biol. Chem. 287, 14880-14895.(doi:10.1074/jbc.M111.336776)
72. Fowler, C. J. 2012 Anandamide uptake explained? Trends Pharmacol. Sci. 33, 181-185.(doi:10.1016/j.tips.2012.01.001)
73. Kaczocha, M., Vivieca, S., Sun, J., Glaser, S. T. & Deutsch, D. G. 2012 Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors. J. Biol. Chem. 287, 3415-3424.(doi:10.1074/jbc.M111.304907)
74. Velkov, T., Horne, J., Laguerre, A., Jones, E., Scanlon, M. J. & Porter, C. J. 2007 Examination of the role of intestinal fatty acid-binding protein in drug absorption using a parallel artificial membrane permeability assay. Chem. Biol. 14, 453-465.(doi:10.1016/j.chembiol.2007.03.009)
75. Atshaves, B. P., Martin, G. G., Hostetler, H. A., McIntosh, A. L., Kier, A. B. & Schroeder, F. 2010 Liver fatty acid-binding protein and obesity. J. Nutr. Biochem. 21, 1015-1032.(doi:10.1016/j.jnutbio.2010.01.005)
76. Benard, G. et al. 2012 Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nat. Neurosci. 15, 558-564.(doi:10.1038/nn.3053)
77. Bartova, A. & Birmingham, M. K. 1976 Effect of delta9-tetrahydrocannabinol on mitochondrial NADH-oxidase activity. J. Biol. Chem. 251, 5002-5006.
78. Athanasiou, A. et al. 2007 Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochem. Biophys. Res. Commun. 364, 131-137.(doi:10.1016/j.bbrc.2007.09.107)
79. Catanzaro, G., Rapino, C., Oddi, S. & Maccarrone, M. 2009 Anandamide increases swelling and reduces calcium sensitivity of mitochondria. Biochem. Biophys. Res. Commun. 388, 439-442.(doi:10.1016/j.bbrc.2009.08.037)
80. Zaccagnino, P., Corcelli, A., Baronio, M. & Lorusso, M. 2011 Anandamide inhibits oxidative phosphorylation in isolated liver mitochondria. FEBS Lett. 585, 429-434.(doi:10.1016/j.febslet.2010.12.032)
81. Zaccagnino, P., D'Oria, S., Romano, L. L., di Venere, A., Sardanelli, A. M. & Lorusso, M. 2012 The endocannabinoid 2-arachidonoylglicerol decreases calcium induced cytochrome c release from liver mitochondria. J. Bioenerg. Biomembr. 44, 273-280.(doi:10.1007/s10863-012-9431-6)
82. Morozov, Y. M., Ben-Ari, Y. & Freund, T. F. 2004 The spatial and temporal pattern of fatty acid amide hydrolase expression in rat hippocampus during postnatal development. Eur. J. Neurosci. 20, 459-466.(doi:10.1111/j.1460-9568.2004.03507.x)
83. di Paola, M. & Lorusso, M. 2006 Interaction of free fatty acids with mitochondria: coupling, uncoupling and permeability transition. Biochim. Biophys. Acta 1757, 1330-1337.(doi:10.1016/j.bbabio.2006.03.024)
84. Korshunov, S. S., Korkina, O. V., Ruuge, E. K., Skulachev, V. P. & Starkov, A. A. 1998 Fatty acids as natural uncouplers preventing generation of O2- and H2O2 by mitochondria in the resting state. FEBS Lett. 435, 215-218.(doi:10.1016/S0014-5793(98)01073-4)
85. Rohas, L. M., St-Pierre, J., Uldry, M., Jager, S., Handschin, C. & Spiegelman, B. M. 2007 A fundamental system of cellular energy homeostasis regulated by PGC-1a. Proc. Natl Acad. Sci. USA 104, 7933-7938.(doi:10.1073/pnas.0702683104)
86. Blum, J. L., Kinsey, G. R., Monian, P., Sun, B., Cummings, B. S., McHowat, J. & Schnellmann, R. G. 2011 Profiling of fatty acids released during calciuminduced mitochondrial permeability transition in isolated rabbit kidney cortex mitochondria. Toxicol. In Vitro 25, 1001-1006.(doi:10.1016/j.tiv.2011.03.014)
87. Palomba, L., Cerioni, L. & Cantoni, O. 2009 Arachidonic acid: a key molecule for astrocyte survival to peroxynitrite. Glia 57, 1672-1679.(doi:10.1002/glia.20879)
88. Calabrese, V., Cornelius, C., Dinkova-Kostova, A. T., Calabrese, E. J. & Mattson, M. P. 2010 Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid. Redox Signal. 13, 1763-1811.(doi:10.1089/ars.2009.3074)
89. Siegmund, S. V., Uchinami, H., Osawa, Y., Brenner, D. A. & Schwabe, R. F. 2005 Anandamide induces necrosis in primary hepatic stellate cells. Hepatology 41, 1085-1095.(doi:10.1002/hep.20667)
90. Rugarli, E. I. & Langer, T. 2012 Mitochondrial quality control: a matter of life and death for neurons. EMBO J. 31, 1336-1349.(doi:10.1038/emboj.2012.38)
91. Han, X. J., Tomizawa, K., Fujimura, A., Ohmori, I., Nishiki, T., Matsushita, M. & Matsui, H. 2011 Regulation of mitochondrial dynamics and neurodegenerative diseases. Acta Med. Okayama 65, 1-10.
92. Galley, H. F. 2011 Oxidative stress and mitochondrial dysfunction in sepsis. Br. J. Anaesth. 107, 57-64.(doi:10.1093/bja/aer093)
93. Huttemann, M. et al. 2012 Regulation of mitochondrial respiration and apoptosis through cell signaling: cytochrome c oxidase and cytochrome c in ischemia/ reperfusion injury and inflammation. Biochim. Biophys. Acta 1817, 598-609.(doi:10.1016/j.bbabio.2011.07.001)
94. Frost, R. A. & Lang, C. H. 2011 mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong? Physiology (Bethesda) 26, 83-96.(doi:10.1152/physiol.00044.2010)
95. Tang, T. et al. 2010 Uncoupling of inflammation and insulin resistance by NF-kB in transgenic mice through elevated energy expenditure. J. Biol. Chem. 285, 4637-4644.(doi:10.1074/jbc.M109.068007)
96. Kobayashi, Y. 2010 The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J. Leukoc. Biol. 88, 1157-1162.(doi:10.1189/jlb.0310149)
97. Spellberg, B. & Edwards Jr, J. E. 2001 Type 1/Type 2 immunity in infectious diseases. Clin. Infect. Dis. 32, 76-102.(doi:10.1086/317537)
98. Klein, T. W. 2005 Cannabinoid-based drugs as antiinflammatory therapeutics. Nat. Rev. Immunol. 5, 400-411.(doi:10.1038/nri1602)
99. Pacher, P. & Mechoulam, R. 2011 Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog. Lipid Res. 50, 193-211.(doi:10.1016/j.plipres.2011.01.001)
100. Cencioni, M. T., Chiurchiu, V., Catanzaro, G., Borsellino, G., Bernardi, G., Battistini, L. & Maccarrone, M. 2010 Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS ONE 5, e8688.(doi:10.1371/journal.pone.0008688)
101. Nakajima, Y., Furuichi, Y., Biswas, K. K., Hashiguchi, T., Kawahara, K., Yamaji, K., Uchimura, T., Izumi, Y. & Maruyama, I. 2006 Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammationthrough NF-kB pathway inhibition. FEBS Lett. 580, 613-619.(doi:10.1016/j.febslet.2005.12.079)
102. Sancho, R., Calzado, M. A., Di Marzo, V., Appendino, G. & Munoz, E. 2003 Anandamide inhibits nuclear factor-kB activation through a cannabinoid receptorindependent pathway. Mol. Pharmacol. 63, 429-438.(doi:10.1124/mol.63.2.429)
103. Dantzer, R. 2006 Cytokine, sickness behavior, and depression. Neurol. Clin. 24, 441-460.(doi:10.1016/j.ncl.2006.03.003)
104. Nunn, A. V., Bell, J. D. & Guy, G. W. 2009 Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: insulin resistance, friend or foe?. Nutr. Metab. (Lond.) 6, 16.(doi:10.1186/1743-7075-6-16)
105. Nunn, A. V., Guy, G. W., Brodie, J. S. & Bell, J. D. 2010 Inflammatory modulation of exercise salience: using hormesis to return to a healthy lifestyle. Nutr. Metab. (Lond.) 7, 87.(doi:10.1186/1743-7075-7-87)
106. Di Marzo, V. 2008 The endocannabinoid system in obesity and type 2 diabetes. Diabetologia 51, 1356-1367.(doi:10.1007/s00125-008-1048-2)